Tempus AI, Inc. TEM continues to strengthen its position in precision medicine through strategic acquisitions. In a move to expand its digital pathology capabilities, the company announced the $81.25 ...

Stocks like Bank of India, Metropolis Healthcare, Dilip Buildcon, LTIMindtree, Brigade Enterprises, Zydus Lifesciences, Coal ...

Affinity Technologies, Inc. (NASDAQ: BIAF, BIAFW) a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer, today announced the closing of its ...

A 57-year-old woman visited Hunan Provincial People's Hospital and The First Affiliated Hospital of Hunan Normal University ...

The offering consists of 1,921,799 shares (the "Shares") of our Common Stock (or pre-funded warrants (the "Pre-Funded Warrants") in lieu thereof) at a purchase price of $2.50 per share (or $2.493 per ...

US-based Mopec has announced an expansion of its partnership with digital pathology technology provider Lumea.

Beginning October 1, 2025, the Lumea device integration will be available as an optional feature on the Maestro Encore. On January 1, 2026, it will become a standard feature, ensuring pathology labs ...

The company was founded in 2015 and specializes in healthcare technology. It focuses on sequencing, molecular genotyping, and pathology testing that is of use to drug-makers in particular. Indeed, the ...

The movie held its No. 1 spot at the box office in the U.S. this weekend after it came out in North America on Sept. 12 through Crunchyroll, a subsidiary of Sony Pictures. The film earned $70 million ...

Anime Movies Demon Slayer: Infinity Castle beats Superman at the box office, a seismic achievement that also guarantees Marvel won't have a top 10 grossing movie for the first time since 2011 Anime ...

The animated Ne Zha 2 is a phenomenon in China, but what does it tell us about Hollywood’s relationship with the country? A report emerged this week that China, in retaliation to President Trump’s ...